Skip to main content
. 2021 Apr 20;12:589418. doi: 10.3389/fphar.2021.589418

FIGURE 1.

FIGURE 1

Atorvastatin alters the secretome of monocytes from healthy controls and stroke patients after 24 h of exposure. Atorvastatin increased IL-1RA and TNF-α secretion from stroke patient derived monocytes as well as healthy control monocytes at 8 µM dose. Atorvastatin had no effect on secretions of IL-8, IL-1β and MCP-1 from stroke monocytes, but decreased the MCP-1 secretion from healthy control monocytes. Significance is shown by *p < 0.05.